MLi-2

Overview

MLi-2, a chemical probe, is an orally active and highly selective LRRK2 inhibitor with an IC 50 of 0.76 nM. MLi-2 has the potential for Parkinson’s disease.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Autophagy | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > LRRK2

Product Information

• Catalog No.: HY-100411
• CAS No.: 1627091-47-7
• Molecular Formula: C21H25N5O2
• Molecular Weight: 379.46
• Purity: 99.50%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.87 mg/mL (7.56 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source